Xinlei Wang
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (7)
Transcriptional regulators (TRs) are essential proteins that regulate gene transcription, and their dysregulation defines the oncogenic transcriptional regulatory programs that drive tumor-specific gene expression. Existing pan-cancer resources summarize these programs by aggregating signals across individual datasets, neglecting the context-specific features that capture the diversity of transcriptional regulation underlying cancer heterogeneity. By developing a variational Bayesian hierarchical model named eTRex ( e pigenomics-based T ranscriptional R egulator ex plorer) and applying it to 4,819 cancer-related ATAC-seq datasets, we provide a comprehensive pan-cancer atlas of functional TR profiles that preserve the context-specific features of each dataset. This study reveals both common regulators across diverse malignancies and those with highly specific roles. We extensively validated these findings using independent CRISPR/Cas9 screening, mutation, and transcriptomic datasets. Collectively, this pan-cancer atlas of functional TR profiles represents a comprehensive, biologically interpretable resource for uncovering transcriptional regulatory programs, identifying biomarkers, prioritizing therapeutic targets in oncology, and is freely accessible through an interactive web portal.
Year:
2026
Complex human diseases, including cancer, are linked to genetic factors. Genome-wide association studies (GWASs) are powerful for identifying genetic variants associated with cancer but are limited by their reliance on case–control data. We propose approaches to expanding GWAS by using tumor and paired normal tissues to investigate somatic mutations. We apply penalized maximum likelihood estimation for single-marker analysis and develop a Bayesian hierarchical model to integrate multiple markers, identifying SNP sets grouped by genes or pathways, improving detection of moderate-effect SNPs. Applied to breast cancer data from The Cancer Genome Atlas (TCGA), both single- and multiple-marker analyses identify associated genes, with multiple-marker analysis providing more consistent results with external resources. The Bayesian model significantly increases the chance of new discoveries.
Year:
2025
Imaging-based spatially resolved transcriptomics (SRT) technologies, such as 10X Xenium, MERSCOPE, and CosMx, have revolutionized our ability to study gene expression within the spatial context of tissues at single-cell resolution. The acquisition of such data relies heavily on cell segmentation algorithms, which often produce imperfect boundaries, leading to transcript misassignment. These misassignments can significantly affect downstream analyses, including cell type identification, differential expression analysis, cell-cell communication, and RNA localization. We present MisTIC (Missegmented Transcript Inference Correction), a variational Bayesian model designed to correct transcript misassignment errors without requiring resegmentation. In benchmarking analyses using synthetic data with simulated transcript misassignment, MisTIC demonstrated high sensitivity and specificity in removing misassigned transcripts. In real data applications, MisTIC effectively enhances cell type identification, reduces ambiguity in differential expression analysis, and improves the detection of cell-cell communication. Furthermore, RNA localization analysis based on data corrected by MisTIC revealed that, in T cells located near cancer-associated fibroblasts compared to those farther away, genes involved in T cell activation, inflammation, and cytotoxicity were depleted from cytoplasmic regions despite not being differentially expressed between the two T cell subsets. In conclusion, MisTIC is a powerful tool for correcting transcript misassignment in SRT data. It not only improves the accuracy of routine analyses but also enables novel investigations that provide deeper insights into the dynamics of gene expression.
Year:
2025
With the rise of large-scale genomic studies, large gene lists targeting important diseases are increasingly common. While evaluating each study individually gives valuable insights on specific samples and study designs, the wealth of available evidence in the literature calls for robust and efficient meta-analytic methods. Crucially, the diverse assumptions and experimental protocols underlying different studies require a flexible but rigorous method for aggregation. To address these issues, we propose BiGER, a fast and accurate Bayesian rank aggregation method for the inference of latent global rankings. Unlike existing methods in the field, BiGER accommodates mixed gene lists with top-ranked and top-unranked genes as well as bottom-tied and missing genes, by design. Using a Bayesian hierarchical framework combined with variational inference, BiGER efficiently aggregates large-scale gene lists with high accuracy, while providing valuable insights into source-specific reliability for researchers. Through both simulated and real datasets, we show that BiGER is a useful tool for reliable meta-analysis in genomic studies.
Year:
2025
Motivation Non-informative or diffuse prior distributions are widely employed in Bayesian data analysis to maintain objectivity. However, when meaningful prior information exists and can be identified, using an informative prior distribution to accurately reflect current knowledge may lead to superior outcomes and great efficiency. Results We propose MetaNorm, a Bayesian algorithm for normalizing NanoString nCounter gene expression data. MetaNorm is based on RCRnorm, a powerful method designed under an integrated series of hierarchical models that allow various sources of error to be explained by different types of probes in the nCounter system. However, a lack of accurate prior information, weak computational efficiency, and instability of estimates that sometimes occur weakens the approach despite its impressive performance. MetaNorm employs priors carefully constructed from a rigorous meta-analysis to leverage information from large public data. Combined with additional algorithmic enhancements, MetaNorm improves RCRnorm by yielding more stable estimation of normalized values, better convergence diagnostics and superior computational efficiency. Availability and implementation R Code for replicating the meta-analysis and the normalization function can be found at github.com/jbarth216/MetaNorm.
Year:
2024
Our study aims to explore the long-term performance patterns for deep learning (DL) models deployed in clinic and to investigate their efficacy in relation to evolving clinical practices. We conducted a retrospective study simulating the clinical implementation of our DL model involving 1328 prostate cancer patients treated between January 2006 and August 2022. We trained and validated a U-Net-based auto-segmentation model on data obtained from 2006 to 2011 and tested on data from 2012 to 2022, simulating the model’s clinical deployment starting in 2012. We visualized the trends of the model performance using exponentially weighted moving average (EMA) curves. Additionally, we performed Wilcoxon Rank Sum Test and multiple linear regression to investigate Dice similarity coefficient (DSC) variations across distinct periods and the impact of clinical factors, respectively. Initially, from 2012 to 2014, the model showed high performance in segmenting the prostate, rectum, and bladder. Post-2015, a notable decline in EMA DSC was observed for the prostate and rectum, while bladder contours remained stable. Key factors impacting the prostate contour quality included physician contouring styles, using various hydrogel spacers, CT scan slice thickness, MRI-guided contouring, and intravenous (IV) contrast ( p < 0.0001, p < 0.0001, p = 0.0085, p = 0.0012, p < 0.0001, respectively). Rectum contour quality was notably influenced by factors such as slice thickness, physician contouring styles, and the use of various hydrogel spacers. The quality of the bladder contour was primarily affected by IV contrast. The deployed DL model exhibited a substantial decline in performance over time, aligning with the evolving clinical settings.
Year:
2024
This article provides an in-depth review of computational methods for predicting transcriptional regulators with query gene sets. Identification of transcriptional regulators is of utmost importance in many biological applications, including but not limited to elucidating biological development mechanisms, identifying key disease genes, and predicting therapeutic targets. Various computational methods based on next-generation sequencing (NGS) data have been developed in the past decade, yet no systematic evaluation of NGS-based methods has been offered. We classified these methods into two categories based on shared characteristics, namely library-based and region-based methods. We further conducted benchmark studies to evaluate the accuracy, sensitivity, coverage, and usability of NGS-based methods with molecular experimental datasets. Results show that BART, ChIP-Atlas, and Lisa have relatively better performance. Besides, we point out the limitations of NGS-based methods and explore potential directions for further improvement. Key points An introduction to available computational methods for predicting functional TRs from a query gene set. A detailed walk-through along with practical concerns and limitations. A systematic benchmark of NGS-based methods in terms of accuracy, sensitivity, coverage, and usability, using 570 TR perturbation-derived gene sets. NGS-based methods outperform motif-based methods. Among NGS methods, those utilizing larger databases and adopting region-centric approaches demonstrate favorable performance. BART, ChIP-Atlas, and Lisa are recommended as these methods have overall better performance in evaluated scenarios.
Year:
2024
Collaborators (6)
Steve Jiang
University of Texas Southwestern Medical Center
Zeyu Lu
Assistant Professor
Minnesota State University Mankato
Kaiwen Wang
Assistant Professor of Data Science
Davidson College
Min Chen
Professor
University of Texas at Dallas
Feng Gao
Assistant Professor
University of California, Los Angeles
Yunguan Wang
Assistant Professor
Cincinnati Children's Hospital Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.